135 related articles for article (PubMed ID: 9105852)
1. Hydrolysis of imipenem, meropenem, ceftazidime, and cefepime by multiresistant nosocomial strains of Sphingobacterium multivorum.
Blahová J; Králiková K; Krcméry V; Kubonová K
Eur J Clin Microbiol Infect Dis; 1997 Feb; 16(2):178-80. PubMed ID: 9105852
[No Abstract] [Full Text] [Related]
2. [The effect of cefepime on ceftazidime, cefotaxime and imipenem resistant strains of Acinetobacter, Xanthomonas, Pseudomonas, Flavobacterium, Sphingobacterium and on producers of extended spectrum beta-lactamases (ESBL) with resistance transfer].
Blahová J; Hupková-Lesická M; Králiková K; Krcméry V; Kubonová K
Cas Lek Cesk; 1997 Mar; 136(5):154-6. PubMed ID: 9221190
[TBL] [Abstract][Full Text] [Related]
3. Pharmacodynamics of antimicrobials for the empirical treatment of nosocomial pneumonia: a report from the OPTAMA Program.
Sun HK; Kuti JL; Nicolau DP
Crit Care Med; 2005 Oct; 33(10):2222-7. PubMed ID: 16215374
[TBL] [Abstract][Full Text] [Related]
4. [Comparative activity of cefepime, ceftazidime and imipenem in a mouse infection caused by Klebsiella pneumoniae producing a broad spectrum beta-lactamase].
Ronco E; Lawrence C; Nauciel C
Pathol Biol (Paris); 1998 Oct; 46(8):651-5. PubMed ID: 9871937
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of meropenem, imipenem, cefepime and ceftazidime against Pseudomonas aeruginosa isolates from cystic fibrosis patients.
Christenson JC; Korgenski EK; Daly JA
J Antimicrob Chemother; 2000 Jun; 45(6):899-901. PubMed ID: 10837448
[TBL] [Abstract][Full Text] [Related]
6. [Comparative activity of meropenem and other antibiotics against the pathogens of nosocomial infections].
Sidorenko SV; Rezvan SP; Grudinina SA; Sterkhova GV; Aleksandrova IA
Antibiot Khimioter; 1998; 43(1):4-14. PubMed ID: 9532326
[TBL] [Abstract][Full Text] [Related]
7. Comparative in vitro activity of cefepime (BMY 28142) against multiresistant nosocomial isolates of Pseudomonas aeruginosa.
Voutsinas D; Mavroudis T; Avlamis A; Giamarellou H
Eur J Clin Microbiol Infect Dis; 1989 Oct; 8(10):917-9. PubMed ID: 2512141
[TBL] [Abstract][Full Text] [Related]
8. [Febrile neutropenia: empiric antibiotic therapy from 1975 to 1997].
Klastersky J
Rev Med Brux; 1997 Oct; 18(5):323-7. PubMed ID: 9441328
[TBL] [Abstract][Full Text] [Related]
9. [Sensitivity of multiresistant bacterial strains to imipenem (Tienam)].
Ruczkowska J; Dolna I
Przegl Lek; 1992; 49(5):151-3. PubMed ID: 1438917
[TBL] [Abstract][Full Text] [Related]
10. Activity of cefepime and carbapenems in experimental pneumonia caused by porin-deficient Klebsiella pneumoniae producing FOX-5 beta-lactamase.
Pichardo C; del Carmen Conejo M; Bernabéu-Wittel M; Pascual A; Jiménez-Mejías ME; de Cueto M; Pachón-Ibáñez ME; García I; Pachón J; Martínez-Martínez L
Clin Microbiol Infect; 2005 Jan; 11(1):31-8. PubMed ID: 15649301
[TBL] [Abstract][Full Text] [Related]
11. [Evaluation of the sensitivity to meropenem of some bacterial strains with nosocomial potential].
Dan L; Licker M; Grecu D; Dumitraşcu V; Branea D; Berceanu-Văduva D; Crăciunescu M; Iancu A; Orb C; Holoşpin M; Hogea E; Muntean D; Moldovan R
Bacteriol Virusol Parazitol Epidemiol; 2003; 48(2-3):107-12. PubMed ID: 15341323
[TBL] [Abstract][Full Text] [Related]
12. Postantibiotic effect of carbapenems against Pseudomonas aeruginosa.
Hikida M; Yamazaki Y; Yoshida M; Kawashima K; Nishiki K; Mitsuhashi S
J Antibiot (Tokyo); 1995 Aug; 48(8):891-2. PubMed ID: 7592037
[No Abstract] [Full Text] [Related]
13. Markedly different rates and resistance profiles exhibited by seven commonly used and newer beta-lactams on the selection of resistant variants of Enterobacter cloacae.
Chan WC; Li RC; Ling JM; Cheng AF; Schentag JJ
J Antimicrob Chemother; 1999 Jan; 43(1):55-60. PubMed ID: 10381101
[TBL] [Abstract][Full Text] [Related]
14. Comparative in vivo efficacy of meropenem, imipenem, and cefepime against Pseudomonas aeruginosa expressing MexA-MexB-OprM efflux pumps.
Ong CT; Tessier PR; Li C; Nightingale CH; Nicolau DP
Diagn Microbiol Infect Dis; 2007 Feb; 57(2):153-61. PubMed ID: 16930925
[TBL] [Abstract][Full Text] [Related]
15. New antibiotics.
Friedland IR; Lutsar I
Curr Opin Pediatr; 1998 Feb; 10(1):41-5. PubMed ID: 9529636
[TBL] [Abstract][Full Text] [Related]
16. Utility of serial rectal swab cultures for detection of ceftazidime- and imipenem-resistant gram-negative bacilli from patients in the intensive care unit.
Arbo MD; Hariharan R; Nathan C; Barefoot L; Weinstein RA; Snydman DR
Eur J Clin Microbiol Infect Dis; 1998 Oct; 17(10):727-30. PubMed ID: 9865988
[TBL] [Abstract][Full Text] [Related]
17. [The results of a multicenter study of the comparative activity of cefepime and other antibiotics against the causative agents of severe hospital infections (the Micromax program)].
Sidorenko SV; Strachunskiĭ LS; Akhmedova LI; Beloborodov VB; Bogomolova NS; Bol'shakov LV; Dekhnich AV; Karabak VI; Malikov VE; Pavlova MV; Polikarpova SV; Rudnov VA; Iakovlev VP
Antibiot Khimioter; 1999; 44(11):7-16. PubMed ID: 10629736
[TBL] [Abstract][Full Text] [Related]
18. Comparative in vitro antibacterial activity of the new carbapenem meropenem (SM-7338).
Visser MR; Hoepelman IM; Beumer H; Rozenberg-Arska M; Verhoef J
Eur J Clin Microbiol Infect Dis; 1989 Dec; 8(12):1061-4. PubMed ID: 2695328
[TBL] [Abstract][Full Text] [Related]
19. Prevalent nosocomial gram negative aerobic bacilli and their antimicrobial susceptibility pattern in intensive care unit.
Zafar A
J Pak Med Assoc; 1999 Jul; 49(7):169-72. PubMed ID: 10599205
[TBL] [Abstract][Full Text] [Related]
20. [Antimicrobial susceptibility pattern of nosocomial gram negative pathogens: results from MYSTIC study in Hacettepe University Adult Hospital (2000-2004)].
Zarakolu P; Hasçelik G; Unal S
Mikrobiyol Bul; 2006 Jul; 40(3):147-54. PubMed ID: 17001842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
